Bedste Encode Ideas-podcasts (2024)

1
A Discussion with Jeb Besser, Managing Member at Manchester Management & CEO of Modular Medical 59:26

2+ y ago59:26

59:26

An interview with Jeb Besser, Managing Member at Manchester Management, a $100M AUM hedge fund that makes concentrated investments in micro/small cap health care and technology companies. In February 2022, Jeb also stepped into the CEO role at Modular Medical, a development-stage insulin pump company, where Manchester is the largest shareholder. Du…

1
A Discussion with Grant Hesser, Portfolio Manager at Social Capital, and Jeremy Sobotta, CEO of Perimeter Medical Imaging AI 54:40

2+ y ago54:40

54:40

In January 2022, Social Capital made a C$43.4 million strategic investment in Perimeter Medical Imaging AI (TSX-V: PINK, US: PYNKF) to advance Perimeter's ultra-high-resolution, real-time, imaging technology. In this podcast, we have a conversation with Grant Hesser, Portfolio Manager at Social Capital, and Jeremy Sobotta, CEO of Perimeter Medical,…

1
A Discussion with Gil Aharon of Rosalind Advisors: Biotech Investing, Verona Pharma & Delcath Systems 1:07:21

3y ago1:07:21

1:07:21

An interview with Gil Aharon of Rosalind Advisors, where we discuss his perspective on the macro biotech market. Having run a dedicated life science fund for >10 years, Gil puts today's difficult biotech market into historical context and offers his opinion on why investors should be optimistic for the future. During the interview, we also discuss …

1
A Discussion with Brian Finn of Findell Capital: Biotech Investing, Liquidia & ProQR 48:30

3y ago48:30

48:30

An interview with Brian Finn of Findell Capital, where we discuss his perspective on small-cap investing. During the interview, we discuss two of Brian's favorite health care names, Liquidia and ProQR, as well as his previous success with MiMedx. To learn more about Findell Capital please visit their website https://findell.us/ Companies discussed …

1
A Discussion with George Haywood: Biotech Investing, Synaptogenix & Petros 57:09

3y ago57:09

57:09

An interview with George Haywood, a well-known investor, where we discuss his perspective on biotech investing. During the interview, we cover some of George's previous biotech successes, including AVI Biopharma / Sarepta, Martek & Amarin, and his current favorite biotech names, Synaptogenix & Petros. Companies discussed during the podcast; Synapto…

1
Delcath Systems: Filtering Through Its Past & Future 47:48

3y ago47:48

47:48

An interview with Gerard Michel, CEO of Delcath Systems, where Gerard reflects back on his time with Vericel, the decision to become CEO of Delcath, the initial NDA submission for the HEPZATO™ KIT, and the preliminary data release from the Phase 3 FOCUS study. Gerard also addresses the future for Delcath, including the impending full Phase 3 FOCUS …

1
Bright Minds Biosciences & Next Generation Psychedelics 43:43

3y ago43:43

43:43

An interview with Gideon Shapiro, Co-Founder & VP of Discovery at Bright Minds Biosciences, where we discuss recent and upcoming events in psychedelic drug development. We cover Bright Minds pipeline of 5HT2 agonists, the importance of FDA's approval of Spravato, and Compass's impending Ph2b psilocybin data, among other topics relevant in the psych…

Podcasts der er værd at lytte til

Encode Ideas Podcasts

Podcasts der er værd at lytte til

1
Encode Ideas: Plainspoken Biotech and Medtech Interviews

Encode Ideas, L.P.

1
A Discussion with Jeb Besser, Managing Member at Manchester Management & CEO of Modular Medical 59:26

1
A Discussion with Grant Hesser, Portfolio Manager at Social Capital, and Jeremy Sobotta, CEO of Perimeter Medical Imaging AI 54:40

1
A Discussion with Gil Aharon of Rosalind Advisors: Biotech Investing, Verona Pharma & Delcath Systems 1:07:21

1
A Discussion with Brian Finn of Findell Capital: Biotech Investing, Liquidia & ProQR 48:30

1
A Discussion with George Haywood: Biotech Investing, Synaptogenix & Petros 57:09

1
Delcath Systems: Filtering Through Its Past & Future 47:48

1
Bright Minds Biosciences & Next Generation Psychedelics 43:43

Hurtig referencevejledning